# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Growing Portfolio of Patents Further Advances the Company's Mission to Develop Fully Implanted Devices for Those Suffering ...
Ascendiant Capital analyst Edward Woo maintains Envoy Medical (NASDAQ:COCH) with a Buy and raises the price target from $8.5...
Glen Taylor, Committed Investor and Believer in Envoy Medical's Mission to Help People with Significant Hearing Loss, Provi...
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.2...
Ascendiant Capital analyst Edward Woo initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Pric...
Envoy Medical in Position to Leverage its Sensor Technology WHITE BEAR LAKE, MN, June 05, 2024 (GLOBE NEWSWIRE) -- Envoy Medic...